Skip to main content

Paravasthu Mukund's Form 4 filing

NovoCure Ltd (NVCR) · filed Mar 5, 2026

Accession no.
0002039078-26-000005
Filed
Mar 5, 2026
Trade date
Mar 3-5, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $667.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Paravasthu MukundCIK 0002039078Officer (Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2026Ordinary SharesAGrant or awardAcquired+45,112$0.00$0121,455Direct
Mar 4, 2026Ordinary SharesSSaleDisposed−5,377$13.31F3−$71,567.87116,078Direct
Mar 5, 2026Ordinary SharesSSaleDisposed−43,246$13.77F4−$595,497.4272,832Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 3, 2026Ordinary SharesAGrant or awardAcquired+7,518$0.00$07,518Direct
Mar 3, 2026Ordinary SharesAGrant or awardAcquired+58,488$0.00$066,006Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $13.74 USD to $14.07 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)